Karen Schreiber: Advancing Thrombosis Epidemiology Through Global Collaboration at ISTH 2026
Karen Schreiber, Scientific and Clinical Lead at Danish Centre for Expertise in Rheumatology (CeViG) and Danish Hospital for Rheumatic Diseases, shared on LinkedIn:
“The one thing that is most fulfilling in academia is seeing young people grow.
I am so proud of my PhD fellow Dina Husum who has given her first big talk at the ISTH 2026 in Paris this week International Society on Thrombosis and Hemostasis – she nailed it!
Persistence and perseverance pay off.
Rehearsing your talk pays off. Preparation pays off. Believe in what you are doing!
ISTH had allocated 2 slots in the session Epidemiology in Thrombosis – Dina showed amazing results on VTE in patients with RMDs. Publication to follow, watch this space 👀.
Thank you for the amazing collaboration of the project Sigrid Braekkan, Stefano Barco, Savino Sciascia, Massimo Radin, Irene Cecchi, Martje Rave, Bente Glintborg – and thank you to the chairs of the session who were most wonderful Mary Cushman and maranuneztoscano.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26